VICORE PHARMA HOLDING AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.3 SEK | +3.72% |
|
+6.00% | +22.00% |
Chart calendar Vicore Pharma Holding AB
2cf5ca37238287461b4c7f3.tswe7E8GD7O3YzDBadB_b6uuMD7YHx0OJ2QTBlIydYc.3KIsiixAWuHkF3iXAoY8NpiYZ1OWcyhvFjZpZDlmR9DbvnWbLE5X0YM8eQ~e305903fe4172ef78c5e11450210bc2e
Upcoming events on Vicore Pharma Holding AB
Past events on Vicore Pharma Holding AB
| 2024-04-17 09:20 am | Kempen Life Sciences Conference |
| 2024-03-06 12:50 pm | TD Cowen Health Care Conference |
| 2024-03-06 09:00 am | Carnegie Healthcare Conference |
| 2024-02-28 02:00 am | Q4 2023 Earnings Release |
| 2024-02-13 10:40 am | Oppenheimer Healthcare Life Sciences Conference |
| 2024-02-07 02:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 2023-11-28 | NLS Days |
| 2023-11-20 | SEB Healthcare Seminar |
| 2023-11-13 | Stifel Healthcare Conference |
| 2023-11-08 | PFF Summit |
| 2023-11-05 | Bio-Europe Conference |
| 2023-11-01 | Q3 2023 Earnings Release |
| 2023-09-18 | IPF Summit |
| 2023-09-14 04:10 am | Pareto Securities Healthcare Conference |
| 2023-09-08 | European Respiratory Summit |
| 2023-08-23 06:00 pm | Q2 2023 Earnings Release |
| 2023-07-05 05:00 am | Extraordinary Shareholders Meeting |
| 2023-05-30 12:00 am | ABGSC Life Science Summit |
| 2023-05-10 | Annual General Meeting |
| 2023-05-03 | Q1 2023 Earnings Release |
Past dividends on Vicore Pharma Holding AB
| 2018-08-15 | 0 SEK |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,01 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 27,6 - | 0,00 0,01 - | 104 |
|
EBITDA Million SEK | Released Forecast Spread | -92,7 -87,3 -6.19% | -150 -130 -14.66% | -291 -350 16.75% | -287 -318 9.58% | -256 -279 8.53% | -149 |
|
EBIT Million SEK | Released Forecast Spread | -94,0 -88,5 -6.29% | -150 -130 -14.69% | -295 -350 15.77% | -291 -318 8.44% | -322 -280 -14.7% | -151 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -93,3 -87,7 -6.45% | -147 -129 -14.25% | -297 -353 15.92% | -289 -311 7.01% | -311 -279 -11.48% | -151 |
|
Net income Million SEK | Released Forecast Spread | -93,1 -87,7 -6.17% | -147 -129 -14.14% | -297 -353 15.95% | -288 -310 7.05% | -311 -279 -11.38% | -151 |
|
EPS SEK | Released Forecast Spread | -2,16 -2,07 -4.4% | -2,71 -2,34 -15.79% | -4,25 -5,03 15.59% | -3,99 -3,89 -2.46% | -3,22 -2,58 -24.69% | -1,35 |
| Announcement Date | 28/02/20 | 26/02/21 | 25/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | ||
|
EBITDA Million SEK | Released Forecast Spread | -64,0 | -65,2 -64,2 -1.54% | -69,0 -60,6 -13.86% | -64,2 -67,0 4.15% | -69,2 -67,1 -3.15% | |
|
EBIT Million SEK | Released Forecast Spread | -64,9 | -66,1 -64,2 -2.98% | -69,8 -60,6 -15.25% | -65,1 -67,2 3.14% | -121 -67,1 -79.78% | |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -80,3 -128 37.46% | -66,4 -63,7 -4.19% | -69,3 -59,9 -15.71% | -63,7 -66,3 3.97% | -112 -66,2 -69.09% | |
|
Net income Million SEK | Released Forecast Spread | -80,4 -128 37.38% | -65,9 | -66,3 -63,6 -4.22% | -69,2 -59,8 -15.73% | -63,6 -66,2 3.97% | -112 -66,1 -69.19% |
|
EPS SEK | Released Forecast Spread | -1,12 -1,51 25.77% | -0,81 -0,78 -3.85% | -0,85 -0,73 -16.35% | -0,58 -0,65 11.16% | -1,00 -0,59 -68.94% | |
| Announcement Date | 25/02/22 | 25/08/22 | 04/05/23 | 24/08/23 | 02/11/23 | 28/02/24 |
More events
Past sector events for Vicore Pharma Holding AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VICO Stock
- Calendar Vicore Pharma Holding AB
